5 completed, 3 not yet recruiting, 2 terminated, 1 unknown. 11 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 11 | Completed 5, Not yet recruiting 3, Terminated 2, Unknown 1 |
Follow crisaborole: new trials by email Literature Review of crisaborole trials Research Report on crisaborole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Utilization of a Microdevice for Psoriasis and Atopic Dermatitis In situ cutaneous microdevice, Triamcinolone, 5-Fluorouracil - Psoriasis, Atopic Dermatitis | Phase 4 | Not yet recruiting | University of California, San Francisco | 10 | 2026-08-01 | 2026-06-03 |
| Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema Placebo Cream, Crisaborole 2% Cream - Atopic Dermatitis (AD), Atopic Eczema | Phase 4 | Not yet recruiting | Jinnah Postgraduate Medical Centre | 270 | 2026-03-01 | 2026-03-06 |
| Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis Crisaborole 2% Topical Application Ointment [EUCRISA, tacrolimus 0.1% - Atopic Dermatitis | Phase 4 | Not yet recruiting | Hayat Abad Medical Complex, Peshawar | 148 | 2026-03-01 | 2026-03-02 |
| Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis Crisaborole 2%, Vehicle treatment, Accelerometry device for children - Atopic Dermatitis | Phase 4 | Terminated | Boston University | 72 | 2022-07-26 | 2025-03-14 |
| Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitis Crisaborole 2% Top Oint - Atopic Dermatitis | Phase 4 | Unknown | Massachusetts General Hospital | 150 | 2020-02-03 | 2021-02-24 |
| Steroid-reducing Effects of Crisaborole Crisaborole, Hydrocortisone Ointment, Triamcinolone ointment - Atopic Dermatitis, Eczema | Phase 4 | Completed | Johns Hopkins University | 24 | 2019-12-17 | 2024-07-19 |
| Response of Children With Atopic Dermatitis (Eczema) to Eucrisa Crisaborole - Atopic Dermatitis, Eczema | Phase 4 | Completed | Ann & Robert H Lurie Children's Hospital of Chicago | 30 | 2019-10-03 | 2022-07-19 |
| Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis Crisaborole 2%, Placebo ointment - Dermatitis, Atopic | Phase 4 | Completed | Innovaderm Research Inc. | 31 | 2019-05-21 | 2021-08-24 |
| A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis Crisaborole - Seborrheic Dermatitis | Phase 4 | Completed | University of Alabama at Birmingham | 30 | 2018-09-01 | 2021-10-29 |
| A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD Crisaborole ointment, 2%, Hydrocortisone butyrate cream, 0.1%, Pimecrolimus cream, 1% - Atopic Dermatitis | Phase 4 | Terminated | Pfizer | 237 | 2018-04-27 | 2022-01-10 |
| A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis Crisaborole ointment 2% - Atopic Dermatitis | Phase 4 | Completed | Pfizer | 137 | 2018-01-16 | 2019-10-10 |
Dermatitis, Atopic (10) · Eczema (2) · Dermatitis, Seborrheic (1) · Mandibulofacial Dysostosis (1) · Psoriasis (1)
Pfizer (2) · Ann & Robert H Lurie Children's Hospital of Chicago (1) · Boston University (1) · Hayat Abad Medical Complex, Peshawar (1) · Innovaderm Research Inc. (1) · Jinnah Postgraduate Medical Centre (1) · Johns Hopkins University (1) · Massachusetts General Hospital (1) · University of Alabama at Birmingham (1) · University of California, San Francisco (1)
United States (8) · Canada (2) · Australia (1) · Germany (1) · Italy (1) · Pakistan (1) · Poland (1) · Sweden (1) · Switzerland (1) · United Kingdom (1)
Anna Fishbein, MD (1) · Anna Grossberg, MD (1) · Boni Elewski, MD (1) · Kevin C Thomas, PhD (1) · Raymond Cho, MD, PhD (1) · Robert Bissonnette, MD (1)
2018 (1)